Univariate and multivariable analysis regarding OS of 685 patients with SM enrolled within the ECNM
Characteristics . | Univariate . | Multivariable . | ||
|---|---|---|---|---|
| HR (95% CI) . | P value . | HR (95% CI) . | P value . | |
| Tryptase (n = 625) ≥/<125μg/L | 3.4 (2.6-4.4) | <.001 | 1.8 (0.9-3.6) | .078 |
| AP (n = 565) ≥/<150U/L | 3.5 (2.7-4.4) | <.001 | 1.4 (0.7-3.0) | .334 |
| β2-microglobulin (n = 158) ≥/<2.5mg/L | 4.8 (2.9-7.9) | <.001 | 2.7 (1.4-5.4) | .004 |
| LDH (n = 533) ≥/<260 U/L | 2.0 (1.5-2.7) | <.001 | 2.1 (1.1-4.0) | .018 |
| Albumin (n = 508) </≥34g/dL | 3.7 (2.7-4.9) | <.001 | 3.3 (1.7-6.5) | .001 |
Characteristics . | Univariate . | Multivariable . | ||
|---|---|---|---|---|
| HR (95% CI) . | P value . | HR (95% CI) . | P value . | |
| Tryptase (n = 625) ≥/<125μg/L | 3.4 (2.6-4.4) | <.001 | 1.8 (0.9-3.6) | .078 |
| AP (n = 565) ≥/<150U/L | 3.5 (2.7-4.4) | <.001 | 1.4 (0.7-3.0) | .334 |
| β2-microglobulin (n = 158) ≥/<2.5mg/L | 4.8 (2.9-7.9) | <.001 | 2.7 (1.4-5.4) | .004 |
| LDH (n = 533) ≥/<260 U/L | 2.0 (1.5-2.7) | <.001 | 2.1 (1.1-4.0) | .018 |
| Albumin (n = 508) </≥34g/dL | 3.7 (2.7-4.9) | <.001 | 3.3 (1.7-6.5) | .001 |
Analysis included variables with receiver operating characteristic-assessed cutoffs.
AP, alkaline phosphatase; CI, confidence interval; HR, hazard ratio; LDH, lactate dehydrogenase